Curated Video
Latest CDC Data Shows Vaccination Numbers Improving
The agency reports nearly 74% of Americans aged 12 or older have gotten at least one dose and 63% of the same group are fully vaccinated.
Curated Video
Moderna Study Suggests Vaccine Protection Wanes
Moderna says the study shows protection from its shot slowly wears off over time.
Curated Video
Fauci Says Hopeful Vaccines Will Get FDA Approval Soon
The Pfizer shot is expected to receive full approval soon.
Curated Video
U.S. Regulators Give Full Approval to Pfizer COVID-19 Vaccine
The FDA's action also may spur more vaccine mandates by companies, universities and local governments.
Curated Video
FDA Trying To Speed Up Full Approval Of Pfizer Vaccine
An agency spokesperson told CNN they're taking an all-hands approach to finish the review.
Bloomberg
FDA Allows Pfizer Covid Booster for Older, At-Risk People
Sep.23 -- Johns Hopkins Bloomberg School of Public Health Vice Dean Joshua Sharfstein discusses Covid vaccine booster shots for high-risk individuals and people over the age of 65. The Bloomberg School of Public Health is supported by...
Curated Video
Moderna Urges FDA To Approve Half-Dose COVID Booster Shot
Regulators are meeting to review whether extra doses of the vaccine should be dispensed and, if so, who should get them and when.
Curated Video
Johnson & Johnson Seeks Authorization For COVID Vaccine Booster Shots
Company research shows a booster shot at either two or six months increased immunity against moderate-to-severe illness.
Curated Video
J&J Says Booster Dose Of Its COVID Shot Prompts Strong Response
Johnson & Johnson says its booster shot prevented 94% of moderate to severe coronavirus cases in the U.S.
Curated Video
Pfizer Seeks FDA Approval For Adult COVID-19 Boosters
A booster would be a full 30 microgram dose given six months after the primary series of two shots given three weeks apart.
Curated Video
State Leaders Push For Booster Expansion Despite Federal Guidance
Federal regulators are reportedly planning imminent expansion as state leaders show impatience in deploying preventive shots before winter sets in.
Curated Video
Closing In On Pfizer Boosters For All Adults
Many millions more American adults could be eligible to receive a booster dose of Pfizer's COVID vaccine.
Curated Video
Pfizer COVID-19 Pill Reduced Deaths, Hospitalizations by 89%
The drugmaker says it will ask for FDA authorization as soon as possible.
Curated Video
Fauci, Walensky Tackle Questions On COVID At Senate Hearing
Top health officials sounded off before a key Senate committee about what happens next in the fight against the coronavirus.
Curated Video
U.S.: Pfizer COVID-19 Vaccine Appears Effective For Kids Under 5
The review from the Food and Drug Administration is a key step toward an expected decision to begin vaccinating babies, toddlers and preschoolers.
Curated Video
There's A New Experimental Treatment For Alcohol, Drug Addiction
Naltrexone is already FDA approved, but not as an implant. Options are being studied and if all goes well, one could be greenlighted in 2024.
Curated Video
Government Combats Baby Formula Shortage With 'Operation Fly Formula'
Experts say ramping up formula imports would be a quick way to beef up supply, but restrictive safety regulations and trade policies are in the way.
Curated Video
What We Know About The Vaping-Related Illnesses Plaguing The Nation
Exactly what's causing these illnesses is still largely a mystery.
Curated Video
FDA Warns Purell To Stop Promoting Unproven Health Claims
The FDA sent a letter to Purell over some of its advertised health claims.
Curated Video
FDA Widens Investigation Into AstraZeneca COVID-19 Vaccine
The FDA will also examine data from earlier studies developed by the same scientists to see if similar side effects showed up in other vaccine trials.
Curated Video
Reports: FDA To Consider Boosters For The Immunocompromised
Multiple reports say the FDA is planning to review CDC data in the next week or so.
Curated Video
FDA Approves Video Game Treatment For ADHD
The FDA approved the game, called EndeavorRx, for kids aged 8 through 12.
Bloomberg
Vascepa Is Safe and Should Be Approved by End of Year, Amarin CEO Says
Aug.28 -- John Thero, Amarin Corp. chief executive officer, discusses the company's plans for its cardiovascular drug Vascepa. He speaks with Bloomberg's David Westin on "Balance of Power."
PBS
Pbs Learning Media: Crash Course Government and Politics: Bureaucracy Basics
Bureaucracies tend to be associated with unintelligible rules and time, but they play an important, though controversial, role in governing. From the FDA to the EPA, agencies are established to help the government manage and carry out...